Since both E4B and its substrates, TRA2A and PYCR2, are highly expressed in many cancer tissues and cells, we wanted to know whether E4B can degrade TRA2A and PYCR2 efficiently in the same type of cancer cells. This evidence concerns the gene PYCR2 and cancer.